Cardiovascular risk assessment prior to kidney transplantation

被引:0
作者
Vnucak, M. [1 ,2 ,3 ]
Granak, K. [1 ,2 ,3 ]
Skalova, P. [1 ,2 ,3 ]
Laca, L. [1 ,2 ,3 ]
Mokan, M. [3 ,4 ]
Dedinska, I [1 ,2 ,3 ]
机构
[1] Univ & Lospital Martin, Dept Surg, Kollarova 2, SK-03601 Martin, Slovakia
[2] Univ & Lospital Martin, Transplantat Ctr, Kollarova 2, SK-03601 Martin, Slovakia
[3] Comenius Univ, Jessenius Med Fac, Martin, Slovakia
[4] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2021年 / 122卷 / 11期
关键词
kidney transplantation; coronary artery disease; selective coronarography; cardiovascular risk; CORONARY-ARTERY-DISEASE; EVENTS; ATHEROSCLEROSIS; CARVEDILOL; METOPROLOL; MANAGEMENT; CANDIDATES; RECIPIENTS; MORTALITY; DIALYSIS;
D O I
10.4149/BLL_2021_123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: The objective was to find out risk factors indicating the patients directly to selective coronarography (SCG) to avoid unnecessary non-invasive testing and in their absence to asses low cardiovascular risk and faster inclusion on the waiting list. BACKGROUND: Cardiovascular diseases (CVD) are the most frequent cause of death in dialysed patients. The aim of our retrospective analysis was to identify risk factors for coronary artery disease (CAD) before kidney transplantation (KTx). METHODS: Our retrospective analysis consisted of 55 dialysed patients (46 males, 9 females, p < 0.0001), undergoing SCG before KTx. We divided the patients according to SCG results (negative, n = 40, positive finding, n = 15). RESULTS: We confirmed a significantly lower incidence of diabetic nephropathy (p = 0.0484), ischaemic heart disease (p = 0.0174) and CAD (p = 0.0001) in patients without percutaneous coronary intervention (PCI; negative finding). Haemodynamically significant coronary stenosis correlated with the occurrence of stroke in a patient's history (p = 0.0104). We identified predictors for performing PCI (positive result): type 2 diabetes mellitus (DM) (p = 0.0472), high-density lipoprotein cholesterol 5 1.03 mmol/l (p = 0.0359), total calcium level 5 2 mmol/l (p = 0.0309), phosphate level >= 1.45 mmol/l (OR 0.2034; p = 0.0351). CONCLUSION: In our analysis, patients with DM and poorly managed chronic kidney disease/mineral bone disease were the riskiest subset of the patients with a positive SCG finding (Tab. 4, Fig. 2, Ref. 30). Text in PDF www.elis.sk
引用
收藏
页码:771 / 777
页数:7
相关论文
共 30 条
  • [1] Coronary Artery Disease and Risk of Major Vascular Events After Cerebral Infarction
    Amarenco, Pierre
    Lavallee, Philippa C.
    Labreuche, Julien
    Ducrocq, Gregory
    Juliard, Jean-Michel
    Feldman, Laurent
    Cabrejo, Lucie
    Meseguer, Elena
    Guidoux, Celine
    Adrai, Valerie
    Ratani, Samina
    Kusmierek, Jerome
    Lapergue, Bertrand
    Klein, Isabelle F.
    Gongora-Rivera, Fernando
    Jaramillo, Arturo
    Abboud, Halim
    Olivot, Jean-Marc
    Mazighi, Mikael
    Touboul, Pierre-Jean
    Steg, Philippe Gabriel
    [J]. STROKE, 2013, 44 (06) : 1505 - +
  • [2] Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction
    Amarenco, Pierre
    Lavallee, Philippa C.
    Labreuche, Julien
    Ducrocq, Gregory
    Juliard, Jean-Michel
    Feldman, Laurent
    Cabrejo, Lucie
    Meseguer, Elena
    Guidoux, Celine
    Adrai, Valerie
    Ratani, Samina
    Kusmierek, Jerome
    Lapergue, Bertrand
    Klein, Isabelle F.
    Gongora-Rivera, Fernando
    Jaramillo, Arturo
    Mazighi, Mikael
    Touboul, Pierre-Jean
    Steg, Philippe Gabriel
    [J]. STROKE, 2011, 42 (01) : 22 - 29
  • [3] Aref Ahmed, 2017, World J Transplant, V7, P129, DOI 10.5500/wjt.v7.i2.129
  • [4] Intracranial Atherosclerosis Current Concepts
    Arenillas, Juan F.
    [J]. STROKE, 2011, 42 (01) : S20 - S23
  • [5] Clinical practice: Low HDL cholesterol levels
    Ashen, MD
    Blumenthal, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) : 1252 - 1260
  • [6] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
    Bakris, GL
    Fonseca, V
    Katholi, RE
    McGill, JB
    Messerli, FH
    Phillips, RA
    Raskin, P
    Wright, JT
    Oakes, R
    Lukas, MA
    Anderson, KM
    Bell, DSH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18): : 2227 - 2236
  • [7] A Systematic Review of the Evidence for Pharmacist Care of Patients With Dyslipidemia
    Charrois, Theresa L.
    Zolezzi, Monica
    Koshman, Sheri L.
    Pearson, Glen
    Makowsky, Mark
    Durec, Tamara
    Tsuyuki, Ross T.
    [J]. PHARMACOTHERAPY, 2012, 32 (03): : 222 - 233
  • [8] Metabolic syndrome and atherosclerotic events in renal transplant recipients
    Courivaud, Cecile
    Kazory, Amir
    Simula-Faivre, Dominique
    Chalopin, Jean-Marc
    Ducloux, Didier
    [J]. TRANSPLANTATION, 2007, 83 (12) : 1577 - 1581
  • [9] Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing
    De Lima, JJG
    Sabbaga, E
    Vieira, MLC
    de Paula, FJ
    Ianhez, LE
    Krieger, EM
    Ramires, JAF
    [J]. HYPERTENSION, 2003, 42 (03) : 263 - 268
  • [10] Influence of coronary artery disease assessment and treatment in the incidence of cardiac events in renal transplant recipients
    De Lima, Jose J. G.
    Gowdak, Luis H. W.
    de Paula, Flavio J.
    Arantes, Rodolfo L.
    Ianhez, Luis E.
    Ramires, Jose A. F.
    Krieger, Eduardo M.
    [J]. CLINICAL TRANSPLANTATION, 2010, 24 (04) : 474 - 480